E-LIB Suche - Ergebnisse für: Landier, F.

1

La concentration plasmatique en 25-OH vitamine D est corrél..:

Bataille, S. ; Landier, J.-F. ; Astier, J....
Nutrition Clinique et Métabolisme. 30 (2016) 3 - p. 239 , 2016

Link: https://doi.org/10.1016/..

2

Mortalità a lungo termine dopo trattamento con GH ricombina..:

Carel, J. C. ; Ecosse, E. ; Landier, F....
L'Endocrinologo. 13 (2012) 2 - p. 90-91 , 2012

Link: https://doi.org/10.1007/..

3

GROWTH HORMOSE TREATMENT OF SHORT CHILDREN BORN SMALL FOR C..:

Chaussain, J L ; Landier, F
Pediatric Research. 33 (1993) - p. S62-S62 , 1993

Link: https://doi.org/10.1203/..

4

GROWTH OF PUBERTAL SHORT NORMAL CHILDREN TREATED 3 YEARS WI..:

Job, J C ; Landier, F
Pediatric Research. 33 (1993) - p. S36-S36 , 1993

Link: https://doi.org/10.1203/..

5

New applications of the mitsunobu reaction in the synthesis..:

Arnould, J.C. ; Landier, F. ; Pasquet, M.J.
Tetrahedron Letters. 33 (1992) 47 - p. 7133-7136 , 1992

Link: https://doi.org/10.1016/..

6

Near normalization of adolescent height with growth hormone..:

Lesage, C. ; Walker, J. ; Landier, F....
The Journal of Pediatrics. 119 (1991) 1 - p. 29-34 , 1991

Link: https://doi.org/10.1016/..

7

95 ODIFICATION OF 24 HOUR GROWTH HORMONE (GH) SECRETION AFT..:

Tauber, M T ; Pienkowski, C ; Landier, F..
Pediatric Research. 24 (1988) 4 - p. 533-533 , 1988

Link: https://doi.org/10.1203/..

8

Insulin pump therapy in young children with type 1 diabetes:

Bougnères, P.F. ; Landier, F. ; Lemmel, C...
The Journal of Pediatrics. 105 (1984) 2 - p. 212-217 , 1984

Link: https://doi.org/10.1016/..

9

Long-Term Measures of Dyslipidemia, Inflammation, and Oxida..:

Feillet-Coudray, Christine ; Fouret, Gilles ; Vigor, Claire...
info:eu-repo/semantics/altIdentifier/doi/10.1002/lipd.12128. , 2019

Link: https://hal.science/hal-..

10

Long-Term Measures of Dyslipidemia, Inflammation, and Oxida..:

Feillet-Coudray, Christine ; Fouret, Gilles ; Vigor, Claire...
info:eu-repo/semantics/altIdentifier/doi/10.1002/lipd.12128. , 2019

Link: https://hal.science/hal-..

11

Long-Term Measures of Dyslipidemia, Inflammation, and Oxida..:

Feillet-Coudray, Christine ; Fouret, Gilles ; Vigor, Claire...
info:eu-repo/semantics/altIdentifier/doi/10.1002/lipd.12128. , 2019

Link: https://hal.science/hal-..

12

Long-Term Measures of Dyslipidemia, Inflammation, and Oxida..:

Feillet-Coudray, Christine ; Fouret, Gilles ; Vigor, Claire...
info:eu-repo/semantics/altIdentifier/doi/10.1002/lipd.12128. , 2019

Link: https://hal.science/hal-..

13

Long-Term Measures of Dyslipidemia, Inflammation, and Oxida..:

Feillet-Coudray, Christine ; Fouret, Gilles ; Vigor, Claire...
info:eu-repo/semantics/altIdentifier/doi/10.1002/lipd.12128. , 2019

Link: https://hal.archives-ouv..

14

Long-Term Measures of Dyslipidemia, Inflammation, and Oxida..:

Feillet-Coudray, Christine ; Fouret, Gilles ; Vigor, Claire...
info:eu-repo/semantics/altIdentifier/doi/10.1002/lipd.12128. , 2019

Link: https://hal.science/hal-..

15

Long-Term Measures of Dyslipidemia, Inflammation, and Oxida..:

Feillet-Coudray, Christine ; Fouret, Gilles ; Vigor, Claire...
info:eu-repo/semantics/altIdentifier/doi/10.1002/lipd.12128. , 2019

Link: https://hal.science/hal-..